AXTIAXT INC

Nasdaq axt.com


$ 3.54 $ 0.15 (4.42 %)    

Wednesday, 15-May-2024 15:59:52 EDT
QQQ $ 452.83 $ 6.97 (1.56 %)
DIA $ 399.31 $ 3.70 (0.94 %)
SPY $ 529.09 $ 6.48 (1.24 %)
TLT $ 92.14 $ 1.24 (1.36 %)
GLD $ 220.89 $ 2.80 (1.28 %)
$ 3.54
$ 3.44
$ 0.00 x 0
$ 0.00 x 0
$ 3.35 - $ 3.55
$ 1.89 - $ 5.64
240,170
na
152.17M
$ 1.52
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 05-10-2024 03-31-2024 10-Q
2 03-15-2024 12-31-2023 10-K
3 11-09-2023 09-30-2023 10-Q
4 08-09-2023 06-30-2023 10-Q
5 05-10-2023 03-31-2023 10-Q
6 03-16-2023 12-31-2022 10-K
7 11-10-2022 09-30-2022 10-Q
8 08-12-2022 06-30-2022 10-Q
9 05-09-2022 03-31-2022 10-Q
10 03-15-2022 12-31-2021 10-K
11 11-12-2021 09-30-2021 10-Q
12 08-12-2021 06-30-2021 10-Q
13 05-14-2021 03-31-2021 10-Q
14 03-23-2021 12-31-2020 10-K
15 11-06-2020 09-30-2020 10-Q
16 08-10-2020 06-30-2020 10-Q
17 05-08-2020 03-31-2020 10-Q
18 03-12-2020 12-31-2019 10-K
19 11-08-2019 09-30-2019 10-Q
20 08-08-2019 06-30-2019 10-Q
21 05-08-2019 03-31-2019 10-Q
22 03-11-2019 12-31-2018 10-K
23 11-07-2018 09-30-2018 10-Q
24 08-07-2018 06-30-2018 10-Q
25 05-04-2018 03-31-2018 10-Q
26 03-09-2018 12-31-2017 10-K
27 11-08-2017 09-30-2017 10-Q
28 08-04-2017 06-30-2017 10-Q
29 05-08-2017 03-31-2017 10-Q
30 02-27-2017 12-31-2016 10-K
31 11-04-2016 09-30-2016 10-Q
32 08-05-2016 06-30-2016 10-Q
33 05-06-2016 03-31-2016 10-Q
34 03-11-2016 12-31-2015 10-K
35 11-06-2015 09-30-2015 10-Q
36 08-07-2015 06-30-2015 10-Q
37 05-08-2015 03-31-2015 10-Q
38 03-13-2015 12-31-2014 10-K
39 11-06-2014 09-30-2014 10-Q
40 08-08-2014 06-30-2014 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 wedbush-reiterates-outperform-on-axt-maintains-6-price-target

Wedbush analyst Matt Bryson reiterates AXT (NASDAQ:AXTI) with a Outperform and maintains $6 price target.

 needham-reiterates-buy-on-axt-maintains-5-price-target

Needham analyst Charles Shi reiterates AXT (NASDAQ:AXTI) with a Buy and maintains $5 price target.

 axt-q1-2024-gaap-eps-005-beats-009-estimate-sales-22688m-beat-21564m-estimate

AXT (NASDAQ:AXTI) reported quarterly losses of $(0.05) per share which beat the analyst consensus estimate of $(0.09) by 44.44 ...

 craig-hallum-maintains-buy-on-axt-raises-price-target-to-5

Craig-Hallum analyst Richard Shannon maintains AXT (NASDAQ:AXTI) with a Buy and raises the price target from $3.75 to $5.

 needham-reiterates-buy-on-axt-maintains-5-price-target

Needham analyst Charles Shi reiterates AXT (NASDAQ:AXTI) with a Buy and maintains $5 price target.

 why-agenus-shares-are-trading-lower-by-around-17-here-are-other-stocks-moving-in-mondays-mid-day-session

Shares of Agenus Inc. (NASDAQ: AGEN) fell sharply during Monday’s session. Agenus disclosed a 1-for-20 reverse stock split of ...

 wedbush-maintains-outperform-on-axt-maintains-6-price-target

Wedbush analyst Matt Bryson maintains AXT (NASDAQ:AXTI) with a Outperform and maintains $6 price target.

 b-riley-securities-maintains-buy-on-axt-raises-price-target-to-55

B. Riley Securities analyst Dave Kang maintains AXT (NASDAQ:AXTI) with a Buy and raises the price target from $3.8 to $5.5.

 why-staar-surgical-shares-are-trading-higher-by-around-13-here-are-other-stocks-moving-in-thursdays-mid-day-session

Shares of STAAR Surgical Company (NASDAQ: STAA) rose sharply during Thursday’s session after the company issued strong prelimi...

 axt-shares-move-lower-down-14-premarket-traders-circulate-j-capital-short-report

https://www.jcapitalresearch.com/

 nasdaq-edges-lower-axt-shares-surge-after-q4-results

U.S. stocks traded mixed toward the end of trading, with the Nasdaq Composite falling around 0.2% on Friday. The Dow traded up...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION